Evaluation of parvovirus B19 infection in children with malignant or hematological disorders.

نویسندگان

  • Igge Gustafsson
  • Tove Kaldensjö
  • Anna Lindblom
  • Oscar Norbeck
  • Jan-Inge Henter
  • Thomas Tolfvenstam
  • Kristina Broliden
چکیده

more fundamental question: what is the rationale for treating elite suppressors with cART in the first place? We know that many of these patients are probably infected with fully replication-competent human immunodeficiency virus (HIV)–1 isolates [2, 3]. Furthermore, a comparison of proviral and plasma HIV clones suggests that viral evolution has occurred in these patients, meaning that the virus has to be replicating at low levels [4]. Although the majority of elite suppressors maintain stable CD4 T cell counts, CD4 T cell depletion has been reported in some elite suppressors [5–8], all of whom have had marked levels of immune activation. Immune activation has been shown to be a better correlate of HIV progression than viremia in some studies [9, 10], and in fact, Kaposi sarcoma has been reported in an elite suppressor with relatively high levels of immune activation [7]. In our study, we showed that treatment of an elite suppressor with highly active antiretroviral therapy (HAART) resulted in a marked decline in immune activation even though there was not a significant increase in CD4 T cell count [8]. Thus, one could argue that treatment with HAART will inhibit the low-level viral replication that is probably responsible for the immune activation in elite suppressors. More patients will have to be studied before we can determine whether this strategy generally results in immune reconstitution, but how do we define success in cases in which CD4 T cell counts do not rebound? Elite suppressors have viral loads of !50 copies/mL at baseline, so using commercial viral load assays with cutoff values of 50 copies/mL will be of little help, and it is obviously challenging to monitor these largely asymptomatic patients for other signs of clinical improvement. The CD4 T cell count in our patient stabilized during HAART [8]; this probably should be the minimum criterion used in these cases. Finally, one could ask whether it makes sense to treat all elite suppressors with HAART. Studies have shown that, although these patients have higher levels of immune activation than uninfected subjects [6, 7], the majority maintain stable CD4 T cell counts for long periods of time [8, 11, 12]. Studies comparing large cohorts of elite suppressors and patients who are receiving HAART will be needed to determine whether subtle differences in morbidity and mortality exist; ultimately, this will guide the decision-making process. However, it should be noted that, although many elite suppressors have been clinically stable for 120 years without therapy, nobody has been taking HAART for that long; thus, the long-term consequences of this treatment remain unknown.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Parvovirus B19 Infection Frequency in Placenta of Fetal Loss Cases in Children Medical Center, Tehran, Iran

  Background and Objectives: Infection with parvovirus may induce spontaneous abortion, non-immune hydrops fetalis, and intrauterine death in full term infants. The aim of this study was to determine the frequency of parvovirus B19 in paraffin-embedded formalin fixed placental tissues in lost fetuses by PCR method and comparison with its frequency in healthy full term neonates as controls. Ma...

متن کامل

بررسی عفونت پاروویروسB₁₉در بیماران مبتلا به تالاسمی ماژور استان کردستان

Background: Thalassemia is a hereditary anemia caused by abnormal hemoglobin chain formation.Treatment is through blood transfusion, which improves the symptoms. However, blood transfusion has complications e.g transmission of infection such as Parvovirus B19. The aim of this study was to investigate the incidence of Parvovirus B19 infection in thalassemia major patients in Kurdistan province. ...

متن کامل

Relation between parvovirus B19 infection and fetal mortality and spontaneous abortion

  Background: Infection with parvovirus B19 may cause fetal losses including spontaneous abortion, intrauterine fetal death and non-immune hydropsfetalis. The aim of this study is to determine the frequency of parvovirus B19 in formalin fixed placental tissues in lost fetuses using real-time PCR method.   Methods : In this cross-sectional study, 100 formalin fixed placental tissues with unknown...

متن کامل

Frequency of human Parvovirus B19 among patients with respiratory infection in Iran

Background: Human parvovirus B19 was known as one of the possible cause of mild respiratory tract diseases in previous studies. However, there are some reports of acute obstructive respiratory disease and severe pneumonia. The purpose of current study was to assess the prevalence and clinical features of parvovirus B19 in respiratory infection.    Methods: This study was conducted on...

متن کامل

کم‌خونی شدید و هیدروپس در نوزاد مبتلا به عفونت Parvovirus B 19: گزارش موردی

Background: Anemia at the time of birth may cause some problem like asphyxia, heart failure shock or even death in a neonate. Different etiologies can be considered for this problem. Parvovirus B19, as a viral organism, can cause hydrops fetalis and neonatal anemia and consequent complications. We present here a case of newborn infant with severe anemia who had human parvovirus B19 infection.Ca...

متن کامل

Comparison of the Frequency of CMV and Parvo B19 Infections in Intrauterin Fetal Death and Normal Pregnancy

Background & Aims: Maternal infections with parvovirus B19 and cytomegalovirus (CMV) maybe associated with intrauterine fetal death. The aim of this study was to compare frequency of CMV & Parvovirus B19 Infections in intrauterine fetal death (IUFD) and normal pregnancy. Methods: In a case-control study in Afzalipour Hospital during 2006 placental biopsies were collected from 70 cases of IUFD a...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

دوره 50 10  شماره 

صفحات  -

تاریخ انتشار 2010